Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function
Clinical trial NCT03009162 · COMPLETED
Trial details
- NCT number
- NCT03009162
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2017-06-02
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.